JUDO 1 Guidewire, JUDO 3 Guidewire, JUDO 6 Guidewire

K180795 · Boston Scientific · DQX · Apr 12, 2018 · Cardiovascular

Device Facts

• Record ID: K180795
• Device Name: JUDO 1 Guidewire, JUDO 3 Guidewire, JUDO 6 Guidewire
• Applicant: Boston Scientific
• Product Code: DQX · Cardiovascular
• Decision Date: Apr 12, 2018
• Decision: SESE
• Submission Type: Special
• Regulation: 21 CFR 870.1330
• Device Class: Class 2

Intended Use

Boston Scientific JUDO 1, JUDO 3, and JUDO 6 Guidewires are intended to facilitate the placement of balloon dilatation catheters or other interventional therapeutic devices during percutaneous transluminal coronary angioplasty (PTCA) or other intravascular interventional procedures. These guidewires are not intended for use in the cerebral vasculature.

Device Story

Guidewires facilitate placement of balloon dilatation catheters or interventional devices during PTCA or intravascular procedures; used in clinical settings by physicians. Device consists of stainless steel core wire with tapered distal end; proximal stainless steel coil; distal platinum/nickel radiopaque coil for fluoroscopic visualization; PTFE coating on proximal end; hydrophilic coating on distal portion. Available in 0.014-inch diameter; 190 cm or 300 cm lengths. 190 cm version includes friction fit extension section for exchange; 300 cm version allows exchange without extension. Device aids navigation through vasculature to target site; enables device exchange; provides radiopacity for positioning under fluoroscopy.

Clinical Evidence

Bench testing only. Performance testing included tip flexibility evaluation to support substantial equivalence.

Technological Characteristics

Stainless steel core wire; distal platinum/nickel radiopaque coil; proximal stainless steel coil; PTFE proximal coating; hydrophilic distal coating. 0.014-inch nominal diameter; 190 cm or 300 cm lengths. Straight tip shape. Mechanical device; no software or energy source.

Indications for Use

Indicated for patients undergoing percutaneous transluminal coronary angioplasty (PTCA) or other intravascular interventional procedures requiring placement of balloon dilatation catheters or interventional therapeutic devices. Not for use in cerebral vasculature.

Regulatory Classification

Identification

A catheter guide wire is a coiled wire that is designed to fit inside a percutaneous catheter for the purpose of directing the catheter through a blood vessel.

Special Controls

*Classification.* Class II (special controls). The device, when it is a torque device that is manually operated, non-patient contacting, and intended to manipulate non-cerebral vascular guide wires, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 870.9.

Predicate Devices

• Hornet™ Guidewire (K152231)

Reference Devices

• Hornet™ 10 Guidewire (K152231)
• Hornet™ 14 Guidewire (K152231)
• Stretch Extension Wire (K151840)

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health & Human Services logo on the left and the FDA logo on the right. The FDA logo is in blue and includes the letters "FDA" in a square, followed by the words "U.S. FOOD & DRUG ADMINISTRATION".

April 12, 2018

Boston Scientific Nikki Ibis Principal Regulatory Affairs Specialist Three Scimed Place Maple Grove, Minnesota 55311-1566

Re: K180795

Trade/Device Name: JUDO 1 Guidewire, JUDO 3 Guidewire, JUDO 6 Guidewire Regulation Number: 21 CFR 870.1330 Regulation Name: Catheter Guide Wire Regulatory Class: Class II Product Code: DOX Dated: March 23, 2018 Received: March 27, 2018

## Dear Nikki Ibis:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820);

{1}------------------------------------------------

and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email ([e-mail]) or phone [phone] or 301-796-7100).

Sincerely,

Kenneth J. Cavanaugh -S

for

Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

| DEPARTMENT OF HEALTH AND HUMAN SERVICES | |
|-------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Food and Drug Administration | |
| <b>Indications for Use</b> | Form Approved: OMB No. 0910-0120<br>Expiration Date: 06/30/2020<br>See PRA Statement below. |
| 510(k) Number (if known) | K180795 |
| Device Name | JUDOTM 1 Guidewire<br>JUDOTM 3 Guidewire<br>JUDOTM 6 Guidewire |
| Indications for Use (Describe) | Boston Scientific JUDO 1, JUDO 3, and JUDO 6 Guidewires are intended to facilitate the placement of balloon dilatation<br>catheters or other interventional therapeutic devices during percutaneous transluminal coronary angioplasty (PTCA) or<br>other intravascular interventional procedures. These guidewires are not intended for use in the cerebral vasculature. |
| Type of Use (Select one or both, as applicable) | <label><input checked="checked" type="checkbox"/> Prescription Use (Part 21 CFR 801 Subpart D)</label> <label><input type="checkbox"/> Over-The-Counter Use (21 CFR 801 Subpart C)</label> |

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

***DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.***

The burden time for this collection of information is estimated to average 79 hours per response, including the
time to review instructions, search existing data sources, gather and maintain the data needed and complete
and review the collection of information. Send comments regarding this burden estimate or any other aspect
of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services
Food and Drug Administration
Office of Chief Information Officer
Paperwork Reduction Act (PRA) Staff
[e-mail]

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of
information unless it displays a currently valid OMB number."

| FORM FDA 3881 (7/17) | Page 1 of 1 |
|----------------------|-------------|
|----------------------|-------------|

.

.

1

1

134000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000

{3}------------------------------------------------

# 510(k) Summary
per 21 CFR §807.92

| Sponsor: | Boston Scientific Corporation<br>300 Boston Scientific Way<br>Marlborough, Massachusetts 01752<br>USA | | |
|---------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------|---------|------------------|
| Contact Name and<br>Information | Nikki M Ibis<br>Three Scimed Place<br>Maple Grove, MN 55311-1566<br>Phone: [phone]<br>Fax: [phone]<br>e-mail: [e-mail] | | |
| Prepared | 23 March 2018 | | |
| Proprietary Name | JUDO™ 1 Guidewire<br>JUDO™ 3 Guidewire<br>JUDO™ 6 Guidewire | | |
| Common Name | Catheter Guide Wire | | |
| Product Code | DQX | | |
| Classification | Class II, 21 CFR Part 870.1330 | | |
| Predicate Device | Hornet™ Guidewire | K152231 | 12 February 2016 |
| Reference<br>Device(s) | Hornet™ 10 Guidewire<br>Hornet™ 14 Guidewire | K152231 | 12 February 2016 |

{4}------------------------------------------------

#### Device Description

The Boston Scientific JUDO 1, JUDO 3, and JUDO 6 Guidewires are available with a nominal diameter of 0.014 inches (0.37 mm) and in nominal lengths of 190 cm or 300 cm. The guidewires are composed of a stainless steel core wire which tapers at the distal end. The tapered distal end of the guidewire is covered with a proximal stainless steel coil and a distal platinum/nickel radiopaque coil that allows for visualization while using fluoroscopy. The proximal end of the guidewire contains a polytetrafluoroethylene (PTFE) coating and the distal portion of the wire is coated with a hydrophilic coating. The guidewires are available in a straight tip shape only.

The 190 cm guidewires are designed with a 2.1 cm friction fit extension section for exchange of Over-the-Wire systems by using the Stretch Extension Wire (K151840). The 300 cm guidewire allows exchange of therapeutic devices without the use of an extension wire or exchange system.

#### Indications for Use / Intended Use

Boston Scientific JUDO 1, JUDO 3, and JUDO 6 Guidewires are intended to facilitate the placement of balloon dilatation catheters or other interventional therapeutic devices during percutaneous transluminal coronary angioplasty (PTCA) or other intravascular interventional procedures. These guidewires are not intended for use in the cerebral vasculature.

## Comparison of Technological Characteristics

The JUDO 1, JUDO 3, and JUDO 6 Guidewires incorporate substantially equivalent design, packaging, fundamental technology, manufacturing processes, sterilization process and intended use as those featured in the predicate, Hornet™ Guidewire, K152231.

#### Non-Clinical Test Summary

Bench testing was performed to support a determination of substantial equivalence. The result of the test provides reasonable assurance that the proposed devices with the modified distal core wire diameter have been designed and tested to assure conformance to the requirements for their intended use. No new safety or performance issues were raised during the testing.

The following device performance test was completed:

Tip Flexibility

{5}------------------------------------------------

# Conclusion

Based on the indications for use, technological characteristics, safety and performance testing, the JUDO™ 1 Guidewire, JUDO™ 3 Guidewire, and JUDO™ 6 Guidewires are appropriate for the stated intended use and are considered to be substantially equivalent to the predicate device (K152231).